|1||NCT04077736||Not yet recruiting
|Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis||
||10||All||18 Years to 70 Years (Adult, Older Adult)||NCT04077736||2019PHB089-02||September 10, 2019||March 30, 2021||June 30, 2021||September 4, 2019||September 4, 2019|
|2||NCT03450122||Active, not recruiting||Study of Adoptive Immunotherapy Using Autologous CD8+ NY-ESO-1-Specific T Cells and the NY-ESO-1 Immunostimulatory Agents LV305 or CMB305 For Patients With Sarcoma||
||Other / Industry / NIH||
||12||All||18 Years and older (Adult, Older Adult)||NCT03450122||2017-0315
|September 13, 2018||December 31, 2019||December 31, 2019||March 1, 2018||September 6, 2019||
† Study has passed its completion date and status has not been verified in more than two years.